United States Antimony CORP

United States Antimony Corporation announces a change in its independent registered public accounting firm due to a merger, engaging Sadler Gibb & Associates, LLC.

United States Antimony Corporation reports Q1 2026 financial results, highlighting strategic growth in critical minerals and government-backed infrastructure expansion.

United States Antimony Corporation reported first quarter 2026 financial results, including $6.8 million in revenue and a $11.3 million net loss, while also achieving $12.8 million in Department of War grant milestones.

United States Antimony Corporation announces Chief Financial Officer Richard Isaak is taking a personal leave of absence, with Shawn Winkler appointed as interim CFO.

United States Antimony Corporation provided an operational update on its Fostung Tungsten Project in Ontario, Canada, releasing a Technical Report Summary with an effective date of January 31, 2026.

United States Antimony Corporation announced a 163% revenue increase in 2025, significant new contracts, and a $4.6 billion inferred tungsten resource, despite operational delays.

United States Antimony Corporation announced a significant revenue surge and a major $245 million contract with the U.S. Defense Logistics Agency, alongside substantial capital raises and strategic acquisitions, despite increased net losses.

United States Antimony Corporation reports significant revenue growth and a return to profitability in Q2 2025, driven by strong antimony prices and strategic expansions.

United States Antimony Corporation reports a significant increase in revenue for Q1 2025, driven by higher antimony prices and increased zeolite sales volume.

United States Antimony Corporation's recent 10-Q filing outlines its capital structure, operational performance, and strategic shifts, including the shutdown of its Mexican subsidiary.

United States Antimony Corporation reported a net income of $202,792 for the second quarter of 2024, despite a loss from continuing operations, and announced the shutdown of its Mexican subsidiary.

United States Antimony Corporation reported its first quarter 2024 financial results, including the shutdown of its Mexican operations and increased revenue in its antimony segment.

United States Antimony Corporation files an amendment to its 2024 annual report to include the inadvertently omitted Consent of Independent Registered Public Accounting Firm.

United States Antimony Corporation's 2024 annual filing reveals increased revenues and a return to gross profit, driven by higher antimony sales and improved operational efficiencies.

United States Antimony Corporation's annual 10-K filing outlines its share structure, recent shutdown of Mexican operations, and financial performance for 2023.

Director Jon R. Marinelli acquired 12,500 shares of United States Antimony Corp. common stock for $7.45 per share.

United States Antimony Corp CFO Richard R. Isaak reported the sale of 100,000 shares of common stock at $9.75 per share.

Melissa Pagen, President & COO of BRZ at United States Antimony Corp, reported a sale of 89,004 common shares.

Lloyd Bardswich, Director and Officer at United States Antimony Corp., reported a transaction involving 59,872 shares of common stock.

United States Antimony Corp Director Blaise A. Aguirre sold 27,000 shares of common stock on March 31, 2026, under a pre-arranged 10b5-1 trading plan.

Lloyd Bardswich, a Director, EVP, and Chief Mining Engineer at United States Antimony Corp (UAMY), disposed of 82,855 shares of common stock across two transactions in late March 2026.

United States Antimony Corporation schedules its 2026 annual meeting to elect directors and vote on doubling authorized common shares.

United States Antimony Corporation has filed a Definitive Proxy Statement (DEFA14A) with the U.S. Securities and Exchange Commission.

United States Antimony Corporation is seeking shareholder approval for key corporate changes, including reincorporating from Montana to Texas, expanding its equity incentive plan, and electing directors, ahead of its virtual annual meeting on July 31, 2025.

United States Antimony Corporation is holding its 2024 annual meeting to vote on director elections, amendments to its corporate charter, a potential reverse stock split, an increase in authorized shares, and the ratification of its independent auditor.

Patrick Dugan and the Estate of Lydia Dugan have filed an exit Schedule 13D, reporting the sale of over 2.3 million shares of United States Antimony Corporation stock and ceasing to be a beneficial owner of more than 5%.

Van Eck Associates Corporation has reported beneficial ownership of 10,369,695 shares, representing 7.23% of the outstanding common stock of United States Antimony Corp.

The Vanguard Group has amended its Schedule 13G filing for United States Antimony Corp, reporting 0% beneficial ownership following an internal realignment.

State Street Corporation has reported a passive beneficial ownership of 5.5% in United States Antimony Corp, holding 7,669,026 common shares.

BlackRock, Inc. has reported a 5.5% beneficial ownership stake in United States Antimony Corp, holding 6,560,151 shares of common stock as a passive investor.

Kenneth M Reed has filed an amended Schedule 13G, disclosing beneficial ownership of 1,507,985 shares, representing 1.26% of United States Antimony Corp's common stock.